Dr Eliane Bodanese, an engineering lecturer at Queen Mary University, was twice rejected for a promotion which was instead ...

Cidara Therapeutics skyrockets 1,165% after positive CD388 data and Merck's acquisition bid. Read why CDTX stock is a Hold.

Pfizer is pursuing pipeline expansions through the Metsera acquisition and a major licensing deal with 3SBio. Find out why ...

Takeda (TSE:4502/NYSE:TAK) today announced positive topline results for the two pivotal Phase 3 randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib ...

Takeda (TAK) announced topline results for the two pivotal Phase 3 randomized, multicenter, double-blind, placebo- and active ...

This week, the Australian Treasurer enacted new regulations to outlaw excessive pricing by Australian supermarkets. These regulations will come into force on 1 July 2026. The Treasurer announced the ...

"Takeda to seek approval of plaque psoriasis pill on Phase III trial data" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Application Writing is the process of drafting a formal request to someone in an authoritative position to seek permission, ask for something, or apply for a post. An application is written in the ...

Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that Health Canada has approved WYNZORA®, a white uniform ...